| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| RVV08808B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
1.0 mg |
$2,135.00
|
 |
BUY
|
| RVV08808A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08804A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08804B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| FHF90710B |
Human Anti-Human ROR1 (SAA0140) mAb |
100 ug |
$430.00
|
|
BUY
|
| FHF90710C |
Human Anti-Human ROR1 (SAA0140) mAb |
1.0 mg |
$1,565.00
|
|
BUY
|
| FHF90710A |
Human Anti-Human ROR1 (SAA0140) mAb |
50 ug |
$300.00
|
|
BUY
|
| CPC539C |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| DHF68801B |
Research Grade Anti-Human CD156b/ADAM17 (MEDI3622) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHF68801A |
Research Grade Anti-Human CD156b/ADAM17 (MEDI3622) |
100 ug |
$475.00
|
|
BUY
|
| DHJ89810A |
Research Grade Anti-Human CD357/TNFRSF18/GITR (REGN 6569) |
100 ug |
$475.00
|
|
BUY
|
| DHJ89810B |
Research Grade Anti-Human CD357/TNFRSF18/GITR (REGN 6569) |
100 ug |
$1,715.00
|
|
BUY
|
| DHJ05001A |
Research Grade Anti-Human IL31 (BMS-981164) |
100 ug |
$475.00
|
|
BUY
|
| DHJ05001B |
Research Grade Anti-Human IL31 (BMS-981164) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHK13704B |
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHK13704A |
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501) mAb |
100 µg |
$420.00
|
|
BUY
|
| DHK23201A |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
100 µg |
$475.00
|
|
BUY
|
| DHK23201B |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00317A |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00317B |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00317B-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
1.0 mg |
$2,310.00
|
|
BUY
|
| DVV00317X-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
0.5 mg |
$1,485.00
|
|
BUY
|
| DHD47201B |
Research Grade Avdoralimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47201A |
Research Grade Avdoralimab |
100 ug |
$380.00
|
|
BUY
|
| DHJ64002B |
Research Grade Azintuxizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ64002A |
Research Grade Azintuxizumab |
100 ug |
$380.00
|
|
BUY
|
| DHD47901B |
Research Grade Bemarituzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47901A |
Research Grade Bemarituzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14801B |
Research Grade Bivatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD14801A |
Research Grade Bivatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02210B |
Research Grade Budigalimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02210A |
Research Grade Budigalimab |
100 ug |
$380.00
|
|
BUY
|
| DHD14203A |
Research Grade Cantuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14203B |
Research Grade Cantuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC21002B |
Research Grade Cergutuzumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHC21002A |
Research Grade Cergutuzumab |
100 ug |
$420.00
|
|
BUY
|
| DHD17401A |
Research Grade Citatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD17401B |
Research Grade Citatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD14205A |
Research Grade Clivatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD14205B |
Research Grade Clivatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHA29103B |
Research Grade Conatumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHA29103A |
Research Grade Conatumumab |
100 ug |
$380.00
|
|
BUY
|
| DHE43204B |
Research Grade Cudarolimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE43204A |
Research Grade Cudarolimab |
100 ug |
$380.00
|
|
BUY
|
| DHD68908B |
Research Grade Dacetuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD68908A |
Research Grade Dacetuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHC09603B |
Research Grade Disitamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09603A |
Research Grade Disitamab |
100 ug |
$380.00
|
|
BUY
|
| DHC25202A |
Research Grade Emactuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHC25202B |
Research Grade Emactuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ62201A |
Research Grade Enavatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ62201B |
Research Grade Enavatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DVV00306B |
Research Grade Etesevimab |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00306A |
Research Grade Etesevimab |
100 ug |
$475.00
|
|
BUY
|
| DHC98803A |
Research Grade Etrolizumab |
100 ug |
$560.00
|
|
BUY
|
| DHC98803B |
Research Grade Etrolizumab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHC29902A |
Research Grade Ganitumab |
100 ug |
$380.00
|
|
BUY
|
| DHC29902B |
Research Grade Ganitumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD14201B |
Research Grade Gatipotuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD14201A |
Research Grade Gatipotuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ42201A |
Research Grade Ianalumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ42201B |
Research Grade Ianalumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE26302B |
Research Grade Iladatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE26302A |
Research Grade Iladatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHE39701A |
Research Grade Imaprelimab |
100 ug |
$380.00
|
|
BUY
|
| DHE39701B |
Research Grade Imaprelimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC21903B |
Research Grade Intetumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC21903A |
Research Grade Intetumumab |
100 ug |
$380.00
|
|
BUY
|
| DHD80902B |
Research Grade Iratumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD80902A |
Research Grade Iratumumab |
100 ug |
$380.00
|
|
BUY
|
| DHD68901A |
Research Grade Iscalimab |
100 ug |
$380.00
|
|
BUY
|
| DHD68901B |
Research Grade Iscalimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC21001A |
Research Grade Labetuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHC21001B |
Research Grade Labetuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC36903B |
Research Grade Levilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC36903A |
Research Grade Levilimab |
100 ug |
$380.00
|
|
BUY
|
| DHD37502A |
Research Grade Lintuzumab |
100 ug |
$420.00
|
|
BUY
|
| DHD37502B |
Research Grade Lintuzumab |
1.0 ug |
$1,520.00
|
|
BUY
|
| DHC98501A |
Research Grade Lorvotuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHC98501B |
Research Grade Lorvotuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD68905B |
Research Grade Lucatumumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD68905A |
Research Grade Lucatumumab |
100 ug |
$380.00
|
|
BUY
|
| DHE14001A |
Research Grade Meplazumab |
100 ug |
$490.00
|
|
BUY
|
| DHE14001B |
Research Grade Meplazumab |
1.0 mg |
$1,790.00
|
|
BUY
|
| DHC08001B |
Research Grade Milatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC08001A |
Research Grade Milatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ04003A |
Research Grade Mirzotamab |
100 ug |
$380.00
|
|
BUY
|
| DHJ04003B |
Research Grade Mirzotamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC90716A |
Research Grade Mosunetuzumab |
100 ug |
$560.00
|
|
BUY
|
| DHC90716B |
Research Grade Mosunetuzumab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHG03401A |
Research Grade Narnatumab |
100 ug |
$380.00
|
|
BUY
|
| DHG03401B |
Research Grade Narnatumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD17205A |
Research Grade Nurulimab |
100 ug |
$380.00
|
|
BUY
|
| DHD17205B |
Research Grade Nurulimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC90712B |
Research Grade Ocaratuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
